AARON DAVIDOFF: Open Payments
NPI 1265207815 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 36 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $216 |
| Teva Pharmaceuticals USA, Inc. | 8 | $194 |
| Otsuka America Pharmaceutical, Inc. | 5 | $126 |
| Lundbeck LLC | 4 | $120 |
| Alkermes, Inc. | 3 | $76 |
| Bausch Health US, LLC | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| HARMONY BIOSCIENCES LLC | 1 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: REXULTI, CAPLYTA, AUSTEDO XR, UZEDY, ARISTADA, APLENZIN, SPRAVATO, WAKIX.
Industry payments across MD — which companies pay providers there.
